Changje Pharmaceutical Publishes Mid-Year Performance
Changje Pharmaceutical (00867) publishes its mid-year performance, with revenue growing 10.8% year-on-year to RMB 40.02 billion, and gross profit growing 7.2% year-on-year to RMB 28.92 billion. Durin